EP1017734A1 - Crosslinkable polyurea polymers - Google Patents
Crosslinkable polyurea polymersInfo
- Publication number
- EP1017734A1 EP1017734A1 EP98951391A EP98951391A EP1017734A1 EP 1017734 A1 EP1017734 A1 EP 1017734A1 EP 98951391 A EP98951391 A EP 98951391A EP 98951391 A EP98951391 A EP 98951391A EP 1017734 A1 EP1017734 A1 EP 1017734A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- radical
- alk
- independently
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
- C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
- C08G18/6666—Compounds of group C08G18/48 or C08G18/52
- C08G18/667—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
- C08G18/6681—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38
- C08G18/6685—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38 with compounds of group C08G18/3225 or polyamines of C08G18/38
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/50—Polyethers having heteroatoms other than oxygen
- C08G18/5021—Polyethers having heteroatoms other than oxygen having nitrogen
- C08G18/5024—Polyethers having heteroatoms other than oxygen having nitrogen containing primary and/or secondary amino groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/81—Unsaturated isocyanates or isothiocyanates
- C08G18/8141—Unsaturated isocyanates or isothiocyanates masked
- C08G18/815—Polyisocyanates or polyisothiocyanates masked with unsaturated compounds having active hydrogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S525/903—Interpenetrating network
Definitions
- the present invention relates to novel crosslinkable polyureas, to a process for the preparation thereof and to the use thereof in the manufacture of mouldings, especially ophthalmic mouldings, for example contact lenses.
- the present invention relates to prepolymers of formula
- Q is an organic radical that comprises at least one crosslinkable group
- CP is a bivalent copolymer fragment consisting of the segments A, B and T, wherein:
- A is a bivalent radical of formula RN A 1 NR' (2a ),
- Ai is the bivalent radical of a polyalkylene glycol or is a linear or branched alkylene radical having from 2 to 24 carbon atoms and each of R and R' independently of the other is hydrogen or unsubstituted or substituted CrC 6 alkyl or, in the case of the amino group that terminates the copolymer fragment, may also be a direct, ring-forming bond;
- T is a bivalent radical of formula C— NH — X— NH-C
- X is a bivalent aliphatic, cycloaliphatic, aliphatic-cycloaliphatic, aromatic, araliphatic or aliphatic-heterocyclic radical; and B is a radical of formula
- Ri and Ri' independently of the other has the meanings given above for R
- B is a bivalent aliphatic, cycloaliphatic, aliphatic-cycloaliphatic, aromatic or araliphatic hydrocarbon radical that is interrupted by at least one amine group of formula
- R 2 and R 2 is hydrogen, a radical Q mentioned above or a radical of formula
- Q is, for example, an olefinically unsaturated, copolymerisable radical that is bonded to the amine nitrogen -NR-, -NR'-, -NR or -NRi'- in a suitable manner, for example directly, by way of a functional group or by way of a bridge member, or that together with -NR-, -NR'-, -NRr or -NR - forms a cyclic ring; in the latter case, R, R', Ri or Ri' is a direct, ring-forming bond.
- the radical Q corresponds, for example, to a radical R 3 mentioned hereinbelow or to a radical of formula
- Qi is, for example, a radical of formula
- Z is linear or branched C 2 -C 12 alkylene
- R 3 is an olefinically unsaturated copolymerisable radical having from 2 to 24 carbon atoms which may be further substituted,
- W is a C 2 -C ⁇ 2 alkylene radical, phenylene radical or C 7 -d 2 aralkylene radical, each of R 4 and R 4 ' independently of the other is hydrogen, C r C alkyl or halogen,
- R 5 is a bivalent aliphatic, cycloaliphatic, aliphatic-cycloaliphatic, aromatic or araliphatic hydrocarbon radical
- R 6 is hydrogen or C ⁇ -C 4 alkyl, each of alk and alk' independently of the other is a linear or branched C C ⁇ alkyiene radical, each of m and n independently of the other is the number 0 or 1 ,
- Z" is C C 6 alkylene
- Pi independently is a radical of the above-mentioned formula (5) wherein Qi is a radical of the above formula (5a), (5b), (5c) or (5e) and n independently is as defined above.
- Z is preferably linear or branched C 2 -C 8 alkylene, more preferably linear C 2 -C 6 alkylene and most preferably linear C 2 -C 4 alkylene.
- Z is 1 ,3- propylene or, especially, 1 ,2-ethylene.
- Suitable substituents on the olef inic C 2 -C 24 radical R 3 are, for example, C C 4 alkoxy, halogen, phenyl or carboxy.
- R 3 is, for example, a radical of formula
- R 7 is hydrogen, C ⁇ -C alkyl or halogen
- each of R 8 and R 9 independently of the other is hydrogen, C ⁇ -C 4 alkyl, phenyl, carboxy or halogen
- Z' is linear or branched d-d ⁇ alkylene or unsubstituted or C ⁇ -C 4 alkyl- or d-C 4 alkoxy- substituted phenylene or C 7 -C 12 aralkylene.
- Z' is a phenylene radical
- it is, for example, unsubstituted or methyl- or methoxy- substituted 1 ,2-, 1 ,3- or 1 ,4-phenylene.
- Z' as a phenylene radical is 1 ,3- or 1 ,4- phenylene.
- Z' is an aralkylene radical
- it is, for example, unsubstituted or methyl- or methoxy- substituted benzylene, wherein the methylene group is bonded to the amine nitrogen in each case.
- Z' as an aralkylene radical is the 1 ,3- or 1 ,4-phenylenemethylene radical, wherein the methylene group is bonded to the amine nitrogen -NH- in each case.
- Z' is preferably unsubstituted or methyl- or methoxy-substituted phenylene or phenylene- methylene or C ⁇ -C ⁇ 2 alkylene, more preferably 1 ,3- or 1 ,4-phenylene or d-Cealkylene, especially CrC 2 alkylene and most preferably methylene.
- p is the number 1 or, preferably, the number 0.
- R 7 is preferably hydrogen, methyl or chlorine and most preferably hydrogen or methyl.
- R 8 and R 9 independently of the other is preferably hydrogen, carboxy, chlorine, methyl or phenyl.
- R 8 is hydrogen, chlorine, methyl or phenyl and R 9 is hydrogen or carboxy.
- R 8 and R 9 are each hydrogen.
- suitable radicals R 3 are vinyl, 2-propenyl, allyl, 2-butenyl, o-, m- or p-vinyl- phenyi, styryl, 2-carboxyvinyl, 2-chloro-2-carboxyvinyl, 1 ,2-dichloro-2-carboxyvinyl, 1 ,2- dimethyl-2-carboxyvinyl and 2-methyl-2-carboxyvinyl.
- R 3 correspond to formula (6) wherein p is 0, R 7 is hydrogen or methyl, R 8 is hydrogen, methyl, chlorine or phenyl and R 9 is hydrogen or carboxy.
- R 3 correspond to the above formula (6) wherein p is 1 , Z' is 1 ,3- or 1 ,4-phenylene or d-C 6 alkylene, especially d-C 2 alkylene, R 7 is hydrogen or methyl and R 8 and R 9 are each hydrogen.
- Z" is preferably C ⁇ -C alkylene, especially methylene or 1 ,1 -dimethylmethylene.
- a second group of suitable radicals Q corresponds to the above formula (5) wherein n is 1 and Qi is a radical of the above formula (5a) wherein m is 0 and for R 3 and Z the meanings and preferences given above apply.
- a further group of suitable radicals Q corresponds to the above formula (5) wherein n is 1 and Qi is a radical of the above formula (5a) wherein m is 1 and for R 3 and Z the meanings and preferences given above apply.
- a further group of suitable radicals Q corresponds to the above formula (5) wherein n is 0 and Qi is a radical of the above formula (5e) wherein for R 3 and Z" the meanings and preferences given above apply.
- variable W is preferably a C 2 -C 6 alkylene radical or a 1 ,3- or 1 ,4-phenylene radical and most preferably a C 2 -C 3 alkylene radical.
- R 4 and R 4 ' independently of the other is preferably hydrogen, methyl or chlorine. Most preferably, each of R and R 4 ' independently of the other is hydrogen or methyl.
- R 5 is, for example, linear or branched C 3 -C ⁇ 8 alkylene or unsubstituted or d-dalkyl- or C ⁇ -C 4 alkoxy-substituted C 6 -C ⁇ 0 arylene, C 7 -d ⁇ aralkylene, C 6 -C ⁇ 0 arylene- d-C 2 alkylene-C 6 -C ⁇ oarylene, C 3 -C 8 cycloalkylene, C 3 -C 8 cycloalkylene-CrC6alkylene, C 3 -C 8 cycloalkylene-C ⁇ -C 2 alkylene-C 3 -C 8 cycloalkylene, d-C 6 alkylene-C 3 -C 8 cycloalkylene- C ⁇ -C 6 alkylene or an aliphatic-heterocyclic radical comprising at least one hydantoin group.
- R 5 as alkylene is preferably a linear or branched C 3 -d 4 alkylene radical, more preferably a linear or branched C 4 -d 2 alkylene radical and most preferably a linear or branched C 6 -do- alkylene radical.
- Some preferred alkylene radicals are 1 ,4-butylene, 2,2-dimethyl-1 ,4- butylene, 1 ,5-pentylene, 2,2-dimethyl-1 ,5-pentylene, 1 ,6-hexylene, 2,2,3- or 2,2,4-trimethyl- 1 ,5-pentylene, 2,2-dimethyl-1 ,6-hexylene, 2,2,3- or 2,2,4- or 2,2,5-trimethyl-1 ,6-hexylene, 2,2-dimethyl-1 ,7-heptylene, 2,2,3- or 2,2,4- or 2,2,5- or 2,2,6-trimethyl-1 ,7-heptylene, 1 ,8- octylene, 2,2-dimethyl-1 ,8-octylene and 2,2,3- or 2,2,4- or 2,2,5- or 2,2,6- or 2,2,7-trimethyl- 1 ,8-octylene.
- R 5 is arylene, it is, for example, naphthylene or especially phenylene, each of which may be substituted, for example, by C ⁇ -C 4 alkyl or by d-C 4 alkoxy.
- R 5 as arylene is 1 ,3- or 1 ,4-phenylene that is substituted by C C alkyl or by d-C 4 alkoxy in the ortho- position to at least one linkage site.
- substituted arylene are 1-methyl-2,4- phenylene, 1 ,5-dimethyl-2,4-phenylene, 1-methoxy-2,4-phenylene and 1-methyl-2,7-naph- thylene.
- R 5 as aralkylene is preferably naphthylalkylene and most preferably phenylalkylene.
- the alkylene group in aralkylene contains preferably from 1 to 12, more preferably from 1 to 6 and most preferably from 1 to 4 carbon atoms. Most preferably, the alkylene group in aralkylene is methylene or ethylene. Some examples are 1 ,3- or 1 ,4-benzylene, naphth-2- yl-7-methylene, 6-methyl-1 ,3- or -1 ,4-benzylene and 6-methoxy-1 ,3- or -1 ,4-benzylene.
- R 5 is cycloalkylene, it is preferably C 5 -C 6 cycloalkylene and most preferably cyclo- hexylene that is unsubstituted or substituted by methyl.
- Some examples are 1 ,3-cyclo- butylene, 1 ,3-cyclopentylene, 1 ,3- or 1 ,4-cyclohexylene, 1 ,3- or 1 ,4-cycloheptylene, 1 ,3- or 1 ,4- or 1 ,5-cyclooctylene, 4-methyl-1 ,3-cyclopentylene, 4-methyl-1 ,3-cyclohexylene, 4,4- dimethyl-1 ,3-cyclohexylene, 3-methyl- or 3,3-dimethyl-1 ,4-cyclohexylene, 3,5-dimethyl-1 ,3- cyclohexylene and 2,4-dimethyl-1 ,4-cyclohexylene.
- R 5 is cycloalkylene-alkylene, it is preferably cyclopentylene-C ⁇ -C 4 alkylene and especially cyclohexylene-C ⁇ -C 4 alkylene, each unsubstituted or mono- or poly-substituted by d-C alkyl, especially methyl. More preferably, the group cycloalkylene-alkylene is cyclo- hexylene-ethylene and, most preferably, cyclohexyiene-methylene, each unsubstituted or substituted in the cyclohexylene radical by from 1 to 3 methyl groups.
- Some examples are cyclopent-1 -yl-3-methylene, 3-methyl-cyclopent-1 -yl-3-methyiene, 3,4-dimethyl-cyclopent-1 - yl-3-methylene, 3,4,4-trimethyl-cyclopent-1 -yl-3-methylene, cyclohex-1 -yl-3- or -4-methyl- ene, 3- or 4- or 5-methyl-cyclohex-1 -yl-3- or -4-methylene, 3,4- or 3,5-dimethyl-cyclohex-1 - yl-3- or -4-methylene and 3,4,5- or 3,4,4- or 3,5,5-trimethyl-cyclohex-1-yl-3- or -4-methylene.
- R 5 is alkylene-cycloalkylene-alkylene, it is preferably C ⁇ -C 4 alkylene-cyclopentylene- C ⁇ -C alkylene and especially d-C 4 alkylene-cyclohexylene-CrC 4 alkylene, each unsubstituted or mono- or poly-substituted by C ⁇ -C 4 alkyl, especially methyl. More preferably, the group alkylene-cycloalkylene-alkylene is ethylene-cyclohexylene-ethylene and, most preferably, is methylene-cyclohexylene-methylene, each unsubstituted or substituted in the cyclohexylene radical by from 1 to 3 methyl groups.
- R 5 is an aliphatic-heterocyclic radical containing hydantoin groups, it may correspond, for example, to formula ⁇
- R 14 and Ru' are each d-C 6 alkylene, preferably C 2 -C 4 alkylene and especially C -C 3 alkylene
- R ⁇ 5 , R 1 5', R ⁇ and R 16 ' are each independently of the others hydrogen, C ⁇ -C 6 alkyl or C 5 -C 7 cycloalkyl, preferably are each independently of the others hydrogen or d-C 4 alkyl and especially are each methyl
- R 5 is d-C ⁇ 2 alkylene and preferably d-C 6 - alkyiene
- R ⁇ 6 and R ⁇ 6 ' are each independently of the other hydrogen or C C 4 alkyl and preferably hydrogen or methyl.
- the radical R 5 in formula (5d) has a symmetrical or, preferably, an asymmetrical structure.
- a preferred group of radicals Qi of formula (5d) comprises those wherein R 5 is linear or branched C 6 -C ⁇ 0 alkylene; cyclohexylene-methylene or cyclohexylene-methylene-cyclo- hexylene each unsubstituted or substituted in the cyclohexyl moiety by from 1 to 3 methyl groups; or phenylene or phenylene-methylene-phenylene each unsubstituted or substituted in the phenyl moiety by methyl.
- the bivalent radical R 5 is derived preferably from a diisocyanate and most preferably from a diisocyanate selected from the group isophorone diisocyanate (IPDI), toluylene-2,4- diisocyanate (TDI), 4,4'-methylenebis(cyclohexyl isocyanate), 1 ,6-diisocyanato-2,2,4- trimethyl-n-hexane (TMDI), methylenebis(phenyl isocyanate), methylenebis(cydohexyl-4- isocyanate) and hexamethylene diisocyanate (HMDI).
- IPDI isophorone diisocyanate
- TDI toluylene-2,4- diisocyanate
- TMDI 4,4'-methylenebis(cyclohexyl isocyanate), 1 ,6-diisocyanato-2,2,4- trimethyl-n-hexane
- TMDI
- Each of the radicals alk and alk' independently of the other is preferably a C 2 -C 8 alkylene radical, more preferably a C 2 -C 4 alkylene radical and most preferably the 1 ,2-ethylene radical.
- R 6 is preferably methyl or especially hydrogen.
- Pi is preferably a radical of the above formula (5) wherein Qi is a radical of the above formula (5a), and most preferably is a radical of formula (5') or (5'") given below.
- each of R 4 and R 4 ' is as defined above and preferably each is methyl.
- Each of R and R' independently of the other is, for example, hydrogen or unsubstituted or, for example, hydroxy- or d-C 4 alkoxy-substituted d-C 6 alkyl, preferably hydrogen or unsubstituted or hydroxy-substituted C C alkyl, more preferably hydrogen, d-C 2 alkyl or hydroxy-C ⁇ -C 2 alkyl and most preferably hydrogen.
- the radicals R and R' may be different or, preferably, identical.
- radical Ai is a polyalkylene glycol radical, it may correspond, for example, to formula
- each of (Alk) and (Alk)' independently of the other is a linear or branched, unsubstituted or, for example, hydroxy-substituted d-C ⁇ 2 alkylene radical; one of the radicals R ⁇ 0 and Rn is hydrogen and the other is methyl; one of the radicals R ⁇ 2 and R ⁇ 3 is hydrogen and the other is C 2 -C 4 alkyl; and each of r, s and t independently of the others is a number from 0 to 100, the sum of (r+s+t) being from 1 to 100.
- each of (Alk) and (Alk') independently of the other is preferably linear or branched C -C 8 alkylene, more preferably linear or branched C 2 -C 6 alkylene and most preferably linear or branched C 2 -C alkylene.
- especially preferred radicals (Alk) and (Alk') are 1 ,2-ethylene, 1 ,2-propylene and 1 ,3-propylene.
- the radicals (Alk) and (Alk') may be different or, preferably, identical.
- Each of r, s and t independently of the others is preferably a number from 0 to 80, the sum of (r+s+t) being from 2 to 80. Most preferably, each of r, s and t independently of the others is a number from 0 to 50, the sum of (r+s+t) being from 4 to 50 and especially from 8 to 50.
- radicals R 12 and R ⁇ 3 one is hydrogen and the other is preferably ethyl.
- Preferred embodiments of the polyalkylene glycol radicals Ai are: (i) a radical of formula (7) wherein each of (Alk) and (Alk') independently of the other is linear or branched C 2 -C 6 alkylene, t is 0, and each of r and s independently of the other is a number from 0 to 100, the sum of (r+s) being from 1 to 100; preferably from 0 to 80, the sum of (r+s) being from 2 to 80; and most preferably from 0 to 50, the sum of (r+s) being from 4 to 50 or especially from 8 to 50; (ii) a radical of formula (7) wherein (Alk) and Alk') are identical and each is linear or branched C 2 -C 4 alkylene, s and t are each 0 and r is a number from 1 to 100, preferably from 2 to 80, more preferably from 4 to 50 and most preferably from 8 to 50.
- A is an alkylene radical, it is preferably an unsubstituted or hydroxy-substituted C 2 -C ⁇ 2 alkylene radical, more preferably an unsubstituted or hydroxy-substituted C 2 -C 8 - alkylene radical and most preferably a C 2 -C 6 alkylene radical, which may in each case be branched or, preferably, linear.
- suitable alkylene segments A are 1 ,2- ethylene, 1 ,2- or 1 ,3-propylene, 2-hydroxy-1 ,3-propylene, 1 ,4-butylene, 1 ,5-pentylene and 1 ,6-hexylene.
- compositions of block copolymers e.g. the polymer fragments of formulae (7) and (7a), mentioned in the text always correspond in each case to a mean statistical composition.
- block copolymer radicals having alternating units, having repeating identical units or having a mixture of alternating and repeating units are included, provided that the ultimate mean statistical composition complies with the specified parameters.
- the prepolymers of the invention may have uniform segments A or, alternatively, two or more structurally different segments A, for example 2 or 3 or, preferably, 2 different segments A.
- X is derived from an aliphatic, cycloaliphatic, aliphatic-cycloaliphatic, aromatic or araliphatic diisocyanate, especially from a diisocyanate selected from the group isophorone diisocyanate (IPDI), toluylene-2,4-diisocyanate (TDI), methylene- bis(cyclohexyl isocyanate), 1 ,6-diisocyanato-2,2,4-trimethyl-n-hexane (TMDI), methyiene- bis(phenyl isocyanate), methylenebis(cyclohexyl isocyanate) and hexamethylene diisocyanate (HMDI).
- IPDI isophorone diisocyanate
- TDI toluylene-2,4-diisocyanate
- TMDI methylene- bis(cyclohexyl isocyanate)
- TMDI methyiene- bis(pheny
- the prepolymers of the invention may have uniform segments T or, alternatively, two or more structurally different segments T.
- the prepolymers may contain uniform segments T.
- the radical Bi may be, for example, linear or branched C 3 -C 24 alkylene or unsubstituted or d-dalkyl-substituted C 6 -d 0 arylene, C 7 -C ⁇ 8 aralkylene, C 6 -C ⁇ oarylene-C ⁇ -C 2 alkylene-C 6 -C 10 - arylene, C 3 -C 8 cycloaikylene, C 3 -C 8 cycloalkylene-C C 6 alkylene, C 3 -C 8 cycloalkylene-d-C 2 - alkyiene-C 3 -C 8 cycloalkylene or d-C 6 alkylene-C 3 -C 8 cycloalkylene-C ⁇ -C 6 alkylene, each of which is interrupted by at least one group -N(R 2 )- of formula (3), preferably by from 1 to 3 or especially 1 or 2 identical or different groups of formula (3), more preferably by 1 or 2 identical groups of formula
- the radical B is a linear or branched C 4 -C 24 alkylene radical that is interrupted by from 1 to 3 groups, preferably 1 or 2 groups and especially by one group of the aboveformula (3).
- radical Bi is linear or branched alkylene having from 3 to 14 or especially from 4 to 12 carbon atoms that is interrupted by one group of formula (3).
- R 2 is a radical Q or a radical of formula (4), then, for the segments A, B and T contained therein and for the variable Q, the meanings, preferences and conditions given above apply in each case.
- alk * , alk ** and alk *** independently of the others is a C 2 -d 2 alkylene radical, preferably a C 2 -C 6 alkylene radical and most preferably a C 2 -C alkylene radical;
- I is the number 0 or 1 and especially the number 0 and for R 2 and R 2 ' independently the meanings and preferences given above for R 2 apply in each case.
- the prepolymers according to the invention may have uniform segments B or, alternatively, two or more structurally different segments B.
- the prepolymers may contain one or more different segments B of formula
- the meanings and preferences given above apply in each case.
- the prepolymers contain different segments B, they are preferably in the form of a mixture of 2, 3 or more different segments of the above formula (8a) that are identical with regard to Ri, R/, alk * , alk ** , alk *** and I but differ with regard to the variables R 2 and/or R 2 '.
- the number of segments A in the polymer fragments CP and CP' is preferably greater than the number of segments B.
- the number of segments A and B in the polymer fragments CP and CP' is preferably in a ratio of 1 : 0.01 to 0.5, preferably 1 : 0.05 to 0.4 and most preferably 1 : 0.1 to 0.25.
- the average molecular weight of the polymer fragments CP is, for example, in a range of approximately from 350 to 25 000, preferably from 500 to 10 000 and most preferably from 1000 to 5000.
- the polymer fragment CP is terminated on both sides by a segment A. It is furthermore preferred that any polymer fragments CP' that are present are also terminated by a segment A.
- the prepolymers of formula (1 ) can be prepared in a manner known perse, for example by reacting together a compound of formula
- R R' a compound of formula
- the compounds of formulae (10), (1 1 ) and (12) are known compounds or can be obtained by methods known perse.
- suitable compounds of formula (10) are N,N'- dihydroxyalkyl-alkylenediamines, e.g. N,N'-dihydroxyethyl-C 2 -C 6 alkylenediamines, or preferably bis-aminoalkylene-polyalkylene glycols of various average molecular weights, e.g. so-called Jeffamines having an average molecular weight of, for example, approximately from 200 to 5000, e.g.
- Suitable diiso- cyanates of formula (11 ) are, for example, isophorone diisocyanate (IPDI), toluylene-2,4- diisocyanate (TDI), methylenebis(cyclohexyl isocyanate), 1 ,6-diisocyanato-2,2,4-trimethyi-n- hexane (TMDI), methylenebis(phenyl isocyanate), methylenebis(cyclohexyl isocyanate) and hexamethylene diisocyanate (HMDI).
- IPDI isophorone diisocyanate
- TDI toluylene-2,4- diisocyanate
- TMDI methylenebis(cyclohexyl isocyanate)
- TMDI methylenebis(phenyl isocyanate)
- HMDI hexamethylene diisocyanate
- Examples of suitable compounds of formula (12) are polyamines, e.g. symmetrical or asymmetrical dialkylenetriamines or trialkylenetetramines, e.g. diethylenetriamine, N-2'-aminoethyl-1 ,3-propylenediamine, N,N-bis(3-aminopropyl)- amine, N,N-bis(6-aminohexyl)amine or triethylenetetramine. It is possible to use in the process, for example, one compound each of formulae (10) , (11) and (12) or two or more different compounds of formula(e) (10), (11) and/or (12), there being obtained in the latter case product mixtures of several copolymers of formula (1a).
- One advantageous variant comprises, for example, reacting two or more different compounds of formula (10) with one compound each of formulae (1 1) and (12).
- the reaction of the diamine of formula (10), the polyamine of formula (12) and the diiso- cyanate of formula (11) is advantageously carried out in an aqueous or aqueous-organic medium.
- a suitable medium has been found to be especially a mixture of water and a readily water-soluble organic solvent, e.g. an alkanol, such as methanol, ethanol or iso- propanol, a cyclic ether, such as tetrahydrofuran, or a ketone, such as acetone.
- An especially suitable reaction medium is a mixture of water and a readily water-soluble solvent having a boiling point of from 50 to 85°C, preferably from 50 to 70°C, especially a water/- tetrahydrofuran or a water/acetone mixture.
- the reaction temperature in the first reaction step of the process is, for example, from -5 to 50°C, preferably from 0 to 30°C and most preferably from 2 to 10°C.
- reaction times may vary within wide limits, a time of approximately from 1 to 10 hours, preferably from 2 to 8 hours and most preferably 2 to 3 hours having proved practicable.
- the stoichiometry in the reaction of the compounds of formulae (10), (11 ) and (12) is advantageously so selected that the number of molar equivalents of the amine groups contained in the compounds of formulae (10) and (12) is greater than the number of molar equivalents of the isocyanato groups contained in the compounds of formula (11 ).
- the excess of amine groups in the compounds of formulae (10) and (12) in relation to the isocyanato groups in the compounds of formula (11 ) is from 0.02 to 1 molar equivalent, preferably from 0.05 to 0.8 molar equivalent, more preferably from 0.1 to 0.6 molar equivalent and most preferably from 0.2 to 0.4 molar equivalent.
- the diamine of formula (10) is used in a molar excess in relation to the polyamine of formula (12).
- a molar ratio of the diamine of formula (10) to the polyamine of formula (12) of from 1 : 0.01 to 1 : 0.5, preferably from 1 : 0.05 to 1 : 0.4 and most preferably from 1 : 0.1 to 1 : 0.3 has proved especially advantageous.
- the compound of formula (12) is a triamine
- the compounds of formulae (10), (12) and (11 ) are used, for example, in a molar ratio of 1 equivalent of compound of formula (10), from 0.05 to 0.4 equivalent of compound of formula (12) and from 0.7 to 1.6 equivalents of compound of formula (11 ); preferably 1 equivalent of compound of formula (10), from 0.1 to 0.3 equivalent of compound of formula (12) and from 0.85 to 1.35 equivalents of compound of formula (11 ); and most preferably 1 equivalent of compound of formula (10), approximately 0.2 equivalent of compound of formula (12) and from 1.1 to 1.2 equivalents of compound of formula (11 ).
- the copolymers of formula (1 a) are novel and the invention relates to them also. They are generally liquid or readily meltable compounds that are predominantly water-soluble.
- the average molecular weight of the copolymers of formula (1a) may vary within wide limits, but is advantageously, for example, from 350 to 25 000, preferably from 500 to 10 000 and most preferably from 1000 to 5000.
- the reaction solution containing a copolymer of formula (1 a) which is obtainable according to the first reaction step can be reacted with a compound of formula (13) to form a prepoly- mer of formula (1 ) without being purified or after purification by means of a customary method, e.g. by means of ultrafiltration.
- a customary method e.g. by means of ultrafiltration.
- from 0.1 to 1.5 molar equivalents preferably from 0.2 to 1 molar equivalent and most preferably from 0.25 to 0.6 molar equivalent of compound of formula (13), based in each case on 1 molar equivalent of compound of formula (1a), are used in the process.
- the compounds of formula (13) are in most cases known or can be prepared by methods known per se.
- Examples of preferred compounds of formula (13) are allyl chloride or bromide, acryloyl chloride, methacryloyl chloride, cinnamic acid chloride, maleic acid anhydride, mono- or di-methylmaleic acid anhydride, 2-isocyanatoethyl acrylate or 2- isocyanatoethyl methacrylate.
- Preferred as compounds of formula (14) are those of formula
- the compounds of formula (14) can be prepared in a manner known perse, for example by reacting a diisocyanate, which may, if desired, be mono-masked, of formula
- R 6 , Pi, alk and alk' are each as defined above, in an inert solvent. It is especially advantageous to use here diisocyanates having isocyanate groups of differing reactivity since the formation of isomers and diadducts can thereby be substantially suppressed.
- the differing reactivity can be brought about, for example, by steric hindrance.
- the differing reactivity can also be achieved by masking an isocyanate group in the diisocyanate.
- Masking agents are known from urethane chemistry. They may be, for example, phenols (cresol, xylenol), lactams (e -caprolactam), oximes (acetoxime, benzophenone oxime), active-H methylene compounds (diethyl malonate, ethyl acetoacetate), pyrazoles or benzo- triazoles. Masking agents are described, for example, by Z.W. Wicks, Jr. in Progress in Organic Coatings, 9 (1981 ), pages 3 to 28.
- Suitable inert solvents for the reaction of the compound of formula (15) with a compound of formula (16) are aprotic, preferably polar, solvents, for example hydrocarbons (petroleum ether, methylcyclohexane, benzene, toluene, xylene), halogenated hydrocarbons (chloroform, methylene chloride, trichloroethane, tetrachloroethane, chlorobenzene), ethers (diethyl ether, dibutyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, tetrahydrofuran, dioxane), ketones (acetone, dibutyl ketone, methyl isobutyl ketone), carboxylic acid esters and lactones (ethyl acetate, butyrolactone, valerolactone), alkylated carboxylic acid amides (N,N-dimethylacetamide, N-
- Polar solvents are preferably used.
- the reactants are advantageously used in equimolar quantities.
- the reaction temperature may be, for example, from 0 to 200°C.
- the temperatures may advantageously be in the range of from 0 to 50°C, preferably at room temperature.
- Suitable catalysts are, for example, metal salts, such as alkali metal salts of carboxylic acids, tertiary amines, for example (d-C 6 alkyl) 3 N (triethylamine, tri-n-butylamine), N-methylpyrrolidine, N-methylmorpholine, N,N-dimethylpiperidine, pyridine and 1 ,4-diaza- bicyclooctane.
- Tin salts have been found to be especially effective, especially alkyltin salts of carboxylic acids, for example dibutyltin dilaurate and tin dioctoate.
- the isolation and purification of the compounds prepared is carried out according to known methods, for example by means of extraction, crystallisation, recrystallisation or chromatographic purification methods.
- the compounds of formula (15) are known or can be prepared by methods known perse.
- the compounds of formula (16) are novel and the invention relates to them also. They can be prepared, for example, by reacting approximately 1 molar equivalent of a compound of formula
- R 6 , alk and alk' are each as defined above, with approximately 2 molar equivalents of a compound of formula
- the reaction of the copolymers of formula (1 a) with a compound of formula (13) and the reaction of the compound of formula (17) with a compound of formula (13a) are carried out, where the compounds of formulae (13) and (13a) are carboxylic acid derivatives and, especially, carboxylic acid halides, under the conditions that are customary for amide formation, for example at temperatures of, for example, from 0 to 80°C, preferably from 0 to 50°C and most preferably from 0 to 25°C, in a dipolar aprotic solvent, e.g.
- tetrahydrofuran dioxane, DMSO etc.
- a base e.g. an alkali metal hydroxide
- Suitable stabilisers are, for example, 2,6-dialkylphenols, hydroquinone derivatives, e.g. hydroquinone or hydroquinone monoalkyl ethers, or N-oxides, e.g. 4-hydroxy-2,2,6,6- tetramethyl-piperidin-1 -yl.
- the reaction times may vary within wide limits, a period of, for example, from 30 minutes to 12 hours, preferably from 1 to 6 hours and especially from 2 to 3 hours, generally having been found practicable.
- the compounds of formulae (13) and (13a) are heterocyclic compounds, they may be, for example, cyclic acid anhydrides, for example maleic acid anhydride, which can be converted in a manner known perse with a copolymer of formula (1a) or with a compound of formula (17), respectively, into a corresponding copolymer containing i ide groups.
- cyclic acid anhydrides for example maleic acid anhydride
- the prepolymers of the invention are crosslinkable, but are uncrosslinked or, at least, substantially uncrosslinked; in addition, they are stable, that is to say spontaneous crosslinking as a result of homopolymerisation does not take place.
- the prepolymers of the invention are advantageously liquid or readily meltable or water- soluble; their average molecular weight may vary within wide limits.
- An average molecular weight of, for example, from 350 to 25 000, preferably from 500 to 10 000 and most preferably from 1000 to 5000 has proved advantageous for the prepolymers of the invention.
- the prepolymers of formula (1 ) can be isolated and purified in a manner known perse, for example by extraction, precipitation, crystallisation, recrystaliisation, filtration, ultrafiltration, chromatography, reverse osmosis or dialysis, with ultrafiltration being especially preferred.
- the prepolymers of the invention can be obtained in extremely pure form, for example as solventless liquids or melts or as concentrated aqueous solutions that are free or at least substantially free of reaction products, such as salts, and starting materials or other non-polymeric constituents.
- the preferred purification method for the prepolymers of the invention can be carried out in a manner known perse. It is possible to carry out the ultrafiltration repeatedly, for example from two to ten times. Alternatively, the ultrafiltration can also be carried out continuously until the desired degree of purity is reached.
- the degree of purity selected may, in principle, be as high as desired and is preferably set in such a manner that the content of undesired constituents in the prepolymers is, for example, ⁇ 0.001 % and more preferably ⁇ 0.0001 % (1 ppm).
- the prepolymers may contain in addition, for example as a consequence of their synthesis, constituents that are acceptable from a physiological viewpoint, e.g. sodium chloride, such constituents advantageously being present in an amount of ⁇ 1 %, preferably ⁇ 0.1 %, and most preferably ⁇ 0.01 %.
- the prepolymers of formula (1) according to the invention are, as already mentioned above, crosslinkable in a controlled and extremely effective manner, especially by photo-cross- linking.
- the present invention further relates, therefore, to a polymer that can be obtained by photo- crosslinking of a prepolymer of formula (1 ), in the absence or presence of an additional vinyl comonomer. These crosslinked polymers are water-insoluble.
- a photoinitiator capable of initiating free-radical crosslinking is suitably added.
- suitable photoinitiators that may specifically be mentioned being benzoin methyl ether, 1 -hydroxy- cyclohexylphenyl ketone, Darocure 1173 or Irgacure types.
- the crosslinking can then be brought about by actinic radiation, e.g. UV light, or ionising radiation, e.g. gamma rays or X-rays.
- the photo-polymerisation can be carried out without the addition of a solvent, for example when the prepolymer is a liquid or readily meltable prepolymer, or takes place in a suitable solvent.
- suitable solvents are in principle all solvents that dissolve the polymers according to the invention and the vinyl comonomers which may be additionally used, e.g. water, alcohols, such as lower alkanols, e.g. ethanol or methanol, carboxylic acid amides, such as dimethylformamide, or dimethyl sulfoxide, and mixtures of suitable solvents, e.g. mixtures of water with an alcohol, e.g. a water/ethanol or a water/methanol mixture.
- the photo-crosslinking is preferably effected under solventless or substantially solventless conditions or directly from an aqueous solution of the prepolymers according to the invention which can be obtained as a result of the preferred purification step, ultrafiltration, optionally after the addition of an additional vinyl comonomer.
- photo-crosslinking of an approximately 15 to 90 % aqueous solution can be carried out.
- the process for the preparation of the crosslinked polymers of the invention comprises, for example, photo-crosslinking a prepolymer of formula (1 ), especially in substantially pure form, that is to say, for example, after single or repeated ultrafiltration, under solventless or substantially solventless conditions or in solution, especially in aqueous solution, in the absence or presence of an additional vinyl comonomer.
- the vinyl comonomer that can additionally be used according to the invention in the photo- crosslinking may be hydrophilic or hydrophobic or may be a mixture of a hydrophobic and a hydrophilic vinyl monomer.
- Suitable vinyl monomers include especially those which are customarily used in the manufacture of contact lenses.
- hydrophilic vinyl monomer is understood to mean a monomer that typically produces as homopolymer a polymer that is water-soluble or capable of absorbing at least 10 % by weight water.
- hydrophobic vinyl monomer is understood to mean a monomer that typically produces as homopolymer a polymer that is water-insoluble or capable of absorbing less than 10 % by weight water.
- the proportion of vinyl comonomers, if used, is preferably from 0.5 to 80 units per prepolymer unit of formula (1 ), especially from 1 to 30 units of vinyl comonomer per prepolymer unit of formula (1) and most preferably from 5 to 20 units per prepolymer unit of formula (1 ).
- hydrophobic vinyl comonomer or a mixture of a hydrophobic vinyl comonomer with a hydrophilic vinyl comonomer the mixture containing at least 50 % by weight of a hydrophobic vinyl comonomer.
- mechanical properties of the polymer can be improved without the water content being appreciably reduced.
- both conventional hydrophobic vinyl comonomers and conventional hydrophilic vinyl comonomers are suitable for copolymerisation with a prepolymer of formula (1 ).
- Suitable hydrophobic vinyl comonomers include, without the following being an exhaustive list, C ⁇ -C ⁇ 8 alkyl acrylates and methacrylates, C 3 -C 18 alkylacrylamides and -methacrylamides, acrylonitrile, methacrylonitrile, vinyl-C C ⁇ 8 alkanoates, C 2 -d 8 alkenes, C 2 -d 8 haloalkenes, styrene, CrC 6 alkylstyrene, vinyl alkyl ethers in which the alkyl moiety has from 1 to 6 carbon atoms, C 2 -C 10 perfluoroalkyl acrylates and methacrylates or correspondingly partially fluorinated acrylates and methacrylates, C 3 -C ⁇ 2 perfluoroalkyl-ethyl-thiocarbonylaminoethyl acrylates and methacrylates, acryloxy- and methacryloxy-alkylsiloxanes, N-vin
- Suitable hydrophobic vinyl comonomers include methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, methyl meth- acrylate, ethyl methacrylate, propyl methacrylate, vinyl acetate, vinyl propionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyltoluene, vinyl ethyl ether, perfluorohexylethyl- thiocarbonylaminoethyl methacrylate, isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoroisopropyl methacrylate, hexafluorobuty
- Suitable hydrophilic vinyl comonomers include, without the following being an exhaustive list, hydroxy-substituted lower alkyl acrylates and methacrylates, acrylamide, methacryl- amide, lower alkylacrylamide and -methacrylamide, ethoxylated acrylates and methacrylates, hydroxy-substituted lower alkylacrylamides and methacrylamides, hydroxy-substituted lower alkyl vinyl ethers, sodium ethylenesulfonate, sodium styrenesulfonate, 2-acrylamido- 2-methylpropanesulfonic acid, N-vinylpyrrole, N-vinylsuccinimide, N-vinylpyrrolidone, 2- or 4- vinylpyridine, acrylic acid, methacrylic acid, amino- (the term "amino" also including quaternary ammonium), mono-lower alkylamino- or di-lower alkylamino-lower alkyl acrylates
- hydrophilic vinyl comonomers examples include hydroxyethyl methacrylate, hydroxyethyl acrylate, acrylamide, methacrylamide, dimethylacrylamide, allyl alcohol, vinyl- pyridine, vinylpyrrolidine, glycerol methacrylate, N-(1 ,1-dimethyl-3-oxobutyl)-acrylamide and the like.
- the prepolymers of the invention can be processed in a manner known per se to form mouldings, especially contact lenses, for example by carrying out the photo-crosslinking of the prepolymers of the invention in a suitable contact lens mould.
- the invention further relates, therefore, to mouldings that substantially consist of a prepolymer of the invention.
- Further examples of mouldings of the invention, apart from contact lenses, are biomedical or special ophthalmic mouldings, e.g. intraocular lenses, eye dressings, mouldings for use in surgery, such as heart valves, artificial arteries or the like, and films or membranes, e.g. membranes for controlling diffusion, photo-structurable films for information storage, or photoresist materials, e.g. membranes or mouldings for etch resists or screen print resists.
- a preferred process for the manufacture of mouldings comprises the following steps: a) introducing into a mould a prepolymer of formula (1 ) that is liquid at room temperature or readily meltable and that is substantially free of solvents, in the absence or presence of an additional vinyl comonomer and/or photoinitiator, b) causing photo-crosslinking for a period of ⁇ 60 minutes, c) opening the mould so that the moulding can be removed from the mould.
- Another preferred process for the manufacture of mouldings comprises the following steps: a) preparing a substantially aqueous solution of a water-soluble prepolymer of formula (1) in the absence or presence of an additional vinyl comonomer and/or photoinitiator, b) introducing the resulting solution into a mould, c) causing photo-crosslinking for a period of ⁇ 60 minutes, d) opening the mould so that the moulding can be removed from the mould.
- Suitable vinyl comonomers if present, will be the aforementioned comonomers in the amounts given.
- the vinyl comonomers that may be present are advantageously mixed with the prepolymer of the invention first and then introduced into the mould.
- Appropriate moulds are made, for example, of polypropylene.
- Suitable materials for reusable moulds are, for example, quartz, sapphire crystal or metals.
- the mouldings to be manufactured are contact lenses, they can be manufactured in a manner known perse, for example in a conventional spin-casting mould as described, for example, in US-A-3 408 429, or by the full-mould process in a static mould as described, for example, in US-A-4 347 198.
- the photo-crosslinking can be brought about in the mould, for example by actinic radiation, e.g. U V light, or ionising radiation, e.g. gamma rays or X-rays.
- actinic radiation e.g. U V light
- ionising radiation e.g. gamma rays or X-rays.
- the crosslinking may take place in a very short time, for example in ⁇ 60 minutes, advantageously in ⁇ 20 minutes, especially in ⁇ 10 minutes, more especially in ⁇ 5 minutes, even more especially in ⁇ 1 minute and most especially in ⁇ 30 seconds.
- Opening of the mould so that the moulding can be removed from the mould can be carried out in a manner known perse.
- the moulding manufactured according to the invention is a contact lens and the latter has been manufactured under solventless conditions from a previously purified prepolymer of the invention, then it is normally unnecessary for the removal of the moulding to be followed by purification steps, e.g. extraction, because the prepolymers used do not contain any undesired low-molecular-weight constituents; consequently, the crosslinked product also is free or substantially free of such constituents and subsequent extraction can be dispensed with.
- the contact lens can accordingly be converted into a ready-for-use contact lens directly in conventional manner by hydration. Suitable forms of hydration capable of producing ready-for-use contact lenses with a wide variety of water contents are known to the person skilled in the art.
- the contact lens is swelled, for example, in water, in an aqueous salt solution, especially in an aqueous salt solution having an osmolarity of approximately from 200 to 450 milliosmol in 1000 ml (unit: mosm/l), preferably approximately from 250 to 350 mosm/l and especially approximately 300 mosm/l, or in a mixture of water or an aqueous salt solution with a physiologically tolerable polar organic solvent, for example glycerol. Swelling of the prepolymer in water or in aqueous salt solutions is preferred.
- the hydration fluids defined above are preferably pure, that is to say free or substantially free of undesired constituents. Most preferably, the hydration fluid is pure water or a synthetic lachrymal fluid as described above.
- the moulding manufactured according to the invention is a contact lens and the latter has been manufactured from an aqueous solution of a previously purified prepolymer of the invention, the crosslinked product also will not contain any troublesome impurities. There is normally no need, therefore, for subsequent extraction. Since the crosslinking is carried out in a substantially aqueous solution, there is also no need for subsequent hydration.
- the contact lenses obtainable by this process are distinguished by the fact that they are suitable for use as intended without extraction.
- the expression "use as intended” is understood in this context to mean especially that the contact lenses can be inserted into the human eye.
- the contact lenses obtainable according to the invention have a range of unusual and extremely advantageous properties. Among those properties, there may be mentioned, for example, their excellent compatibility with the human cornea, which is due to a balanced ratio of water content, oxygen permeability and mechanical properties.
- the contact lenses of the invention furthermore have a high dimensional stability. Even after autoclaving at, for example, approximately 120°C no changes in shape can be detected.
- the contact lenses of the invention that is to say especially those comprising a crosslinked polymer of a prepolymer of formula (1 )
- the contact lenses of the invention can be manufactured in a very simple and efficient manner compared with the prior art. This is due to several factors. Firstly, the starting materials can be obtained or prepared at little cost. Secondly, there is the advantage that the prepolymers are surprisingly stable and can therefore be subjected to high-grade purification. For crosslinking, therefore, it is possible to use a polymer that requires virtually no subsequent purification, such as, especially, laborious extraction of unpolymerised constituents.
- the crosslinking can be carried out under solventless conditions or in aqueous solution, with the result that subsequent solvent exchange and the hydration step are not necessary.
- the photopolymerisation takes place within a short time, so that the manufacturing process of the contact lenses of the invention can be made extraordinarily economic from that point of view also.
- Example 1 Preparation of a polyurea: 300 g of tetrahydrofuran (THF), 160 g of water, 95.7 g of bis(2-aminopropyl)polyethylene glycol 800, 65.68 g of bis(2-aminopropyl)poly- ethylene glycol 500 and 4.13 g of diethyienetriamine are placed in a glass apparatus.
- THF tetrahydrofuran
- a solution of 48.91 g of isophorone diisocyanate in 35 g of THF is added dropwise with intensive stirring and the reaction mixture is left to react at from 2 to 6°C for approximately a further 25 minutes.
- the internal temperature is then increased over a period of approximately 3 hours to from 25 to 30°C and, when the reaction is complete, the THF is distilled off under reduced pressure using a rotary evaporator.
- the aqueous solution is then purified at room temperature by means of filtration over a 0.45 ⁇ m filter and via ultrafiltration using a 1 kD filter.
- the purified solution is concentrated and the residue is dried for approximately 1 hour at 70°C/0.1 mbar. A yellowish, highly viscous polyurea is obtained, having 0.31 mol. equiv. of amine/g.
- Example 2 (Preparation of a crosslinkable polyurea): Analogously to Example 1 , 95.7 g of bis(2-aminopropyl)polyethylene glycol 800, 65.68 g of bis(2-aminopropyl)polyethylene glycol 500 and 4.13 g of diethyienetriamine are placed in 300 ml of THF and 160 ml of water, and a solution of 48.91 g of isophorone diisocyanate in 160 ml of THF is added dropwise.
- reaction mixture is left to react at from 3 to 8°C for approximately a further 105 minutes and then 50 ml of 2N sodium hydroxide solution and 50 mg of 4-hydroxy- 2,2,6,6-tetramethylpiperidin-1-yl are added thereto and 7.24 g of acryloyi chloride are added dropwise over a period of approximately 8 minutes. After a further 100 minutes, 3 g of solid sodium hydroxide are added to the reaction mixture and then a further 7.24 g of acryloyi chloride are added dropwise. This is followed by stirring for approximately 2.5 hours at approximately from 2 to 18°C and by removal of the THF from the reaction mixture by distillation.
- the aqueous solution is then purified at room temperature by means of filtration over a 0.45 ⁇ m filter and via ultrafiltration using a 1 kD filter.
- the resulting clear, colourless solution is concentrated at 60°C/30 to 100 mbar until the solids content is 45.7 % by weight.
- a sample is lyophilised and analysed.
- the double bond content of the dried polymer is 0.36 equivalent of double bond/g.
- Example 3 Manufacture of a contact lens: 9.2 mg of a photoinitiator (lrgacure ® 2959) are dissolved in 13.06 g of a 35 % polyurea solution prepared according to Example 2, and the resulting solution is purified by filtration over a 0.45 ⁇ m filter. Then, the polyurea solution provided with the photoinitiator is introduced into a contact lens mould and irradiated for 7.6 seconds, corresponding to a dose of 18 mJ/cm 2 . Colourless transparent lenses having the following physical data are obtained: water content 68 %, elongation at tear > 210 %, modulus 1.228 MPa.
- PEG 500, PEG 800 and PEG 1900 denote bis(2-aminopropyl)polyethylene glycol 500, 800 and 1900;
- BHEED denotes N,N'-bis(2-hydroxyethyl)ethylenediamine;
- DETA denotes diethyienetriamine;
- TETA denotes triethylenetetramine;
- HMDI denotes hexa- methylene-1 ,6-diisocyanate;
- MBCYI denotes 4,4'-methylene-bis(cyclohexyl isocyanate);
- TMDI denotes 1 ,6-diisocyanato-2,2,4-trimethyl-n-hexane;
- IPDI denotes isophorone diisocyanate;
- IEM denotes 2-isocyanatoethyl methacrylate;
- A-CI denotes acryloyi chloride;
- CA-CI denotes cinnamic acid chloride
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Polyurethanes Or Polyureas (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Eyeglasses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Polyamides (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98951391A EP1017734B1 (en) | 1997-09-16 | 1998-09-14 | Crosslinkable polyurea polymers |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97810666 | 1997-09-16 | ||
EP97810666 | 1997-09-16 | ||
PCT/EP1998/005826 WO1999014253A1 (en) | 1997-09-16 | 1998-09-14 | Crosslinkable polyurea polymers |
EP98951391A EP1017734B1 (en) | 1997-09-16 | 1998-09-14 | Crosslinkable polyurea polymers |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1017734A1 true EP1017734A1 (en) | 2000-07-12 |
EP1017734B1 EP1017734B1 (en) | 2002-08-28 |
Family
ID=8230382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98951391A Expired - Lifetime EP1017734B1 (en) | 1997-09-16 | 1998-09-14 | Crosslinkable polyurea polymers |
Country Status (8)
Country | Link |
---|---|
US (1) | US6479587B1 (en) |
EP (1) | EP1017734B1 (en) |
JP (1) | JP4616473B2 (en) |
AR (1) | AR017108A1 (en) |
AU (1) | AU9743298A (en) |
DE (1) | DE69807509T2 (en) |
WO (1) | WO1999014253A1 (en) |
ZA (1) | ZA988420B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004024935A2 (en) | 2002-09-13 | 2004-03-25 | Novartis Ag | Process for analyzing the tear fluid |
WO2004030544A1 (en) | 2002-10-03 | 2004-04-15 | Novartis Ag. | Methods and kits for assays of analytes of interest in tears |
US7977430B2 (en) | 2003-11-25 | 2011-07-12 | Novartis Ag | Crosslinkable polyurea prepolymers |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0971004A1 (en) * | 1998-07-06 | 2000-01-12 | Dsm N.V. | Powder paint binder composition |
US7998412B2 (en) * | 2000-01-07 | 2011-08-16 | Smart Holograms Limited | Ophthalmic device comprising a holographic sensor |
US20050085585A1 (en) * | 2002-10-23 | 2005-04-21 | Quinn Michael H. | Polymerizable materials |
WO2005000109A2 (en) | 2003-06-27 | 2005-01-06 | University Of Maryland Biotechnology Institute | Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
WO2005015184A1 (en) * | 2003-07-30 | 2005-02-17 | Novartis Ag | Reflection hologram sensor in contact lens |
ES2350933T3 (en) * | 2003-08-07 | 2011-01-28 | Eyesense Ag | OPHTHALM SENSOR |
US20050056954A1 (en) * | 2003-09-12 | 2005-03-17 | Devlin Brian Gerrard | Method for making contact lenses |
US7151148B2 (en) * | 2003-09-16 | 2006-12-19 | Acushnet Company | Castable golf ball components using acrylate functional resins |
US20060065138A1 (en) * | 2004-09-30 | 2006-03-30 | Tucker Robert C | Pad printing method for making colored contact lenses |
ATE482248T1 (en) * | 2004-11-22 | 2010-10-15 | Novartis Ag | CROSS-LINKABLE POLYOXYALKYLENE-CONTAINING POLYAMIDE PREPOLYMERS |
US7795359B2 (en) | 2005-03-04 | 2010-09-14 | Novartis Ag | Continuous process for production of polymeric materials |
US9804295B2 (en) | 2005-05-05 | 2017-10-31 | Novartis Ag | Ophthalmic devices for sustained delivery of active compounds |
US7905868B2 (en) | 2006-08-23 | 2011-03-15 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20070037897A1 (en) * | 2005-08-12 | 2007-02-15 | Guigui Wang | Method for making contact lenses |
US7858000B2 (en) | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
EP2038310B1 (en) | 2006-07-12 | 2010-06-09 | Novartis AG | Actinically crosslinkable copolymers for manufacturing contact lenses |
CA2914805C (en) * | 2006-11-06 | 2017-12-12 | Novartis Ag | Ocular devices and methods of making and using thereof |
AR064286A1 (en) | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH |
CN101641206B (en) | 2007-03-22 | 2013-03-20 | 诺瓦提斯公司 | Prepolymers with dangling polysiloxane-containing polymer chains |
US7963954B2 (en) | 2007-04-30 | 2011-06-21 | Medtronic Minimed, Inc. | Automated filling systems and methods |
CA2685474C (en) | 2007-04-30 | 2014-07-08 | Medtronic Minimed, Inc. | Reservoir filling, bubble management, and infusion medium delivery systems and methods with same |
TWI419719B (en) | 2007-08-31 | 2013-12-21 | Novartis Ag | Contact lens products |
CN101903807B (en) | 2007-12-20 | 2013-01-09 | 诺瓦提斯公司 | Method for making contact lenses |
EP2265430B1 (en) * | 2008-04-02 | 2011-10-12 | Novartis AG | Method and system for making ophthalmic devices using stereolithography and a single moulding surface |
TWI506333B (en) * | 2008-12-05 | 2015-11-01 | Novartis Ag | Ophthalmic devices for delivery of hydrophobic comfort agents and preparation method thereof |
MY151232A (en) * | 2008-12-30 | 2014-04-30 | Novartis Ag | Tri-functional uv-absorbing compounds and use thereof |
CA2761218C (en) * | 2009-05-22 | 2016-06-28 | Novartis Ag | Actinically-crosslinkable siloxane-containing copolymers |
JP5575881B2 (en) | 2009-05-22 | 2014-08-20 | ノバルティス アーゲー | Actinically crosslinkable siloxane-containing copolymer |
KR101585290B1 (en) | 2009-09-15 | 2016-01-13 | 노파르티스 아게 | Prepolymers suitable for making ultra-violet absorbing contact lenses |
KR101938900B1 (en) | 2010-07-29 | 2019-01-15 | 노파르티스 아게 | Colored contact lenses and method of making the same |
TWI573818B (en) | 2010-07-30 | 2017-03-11 | 諾華公司 | Amphiphilic polysiloxane prepolymers and uses thereof |
BR112013008221B1 (en) | 2010-10-06 | 2020-02-11 | Alcon Inc. | PRE-POLYMER PROCESSABLE IN WATER, SILICON HYDROGEL CONTACT LENS AND ITS MANUFACTURING METHOD |
HUE044765T2 (en) | 2010-10-06 | 2019-11-28 | Novartis Ag | Polymerisable chain-extended polysiloxanes with pendant hydrophilic groups |
CN103168067B (en) | 2010-10-06 | 2015-08-05 | 诺华股份有限公司 | Can the silicone-containing prepolymer and uses thereof of water treatment |
US9623614B2 (en) | 2010-11-10 | 2017-04-18 | Novartis Ag | Method for making contact lenses |
HUE030629T2 (en) | 2010-12-13 | 2017-05-29 | Novartis Ag | Ophthalmic lenses modified with functional groups and methods of making thereof |
KR20180096806A (en) | 2010-12-14 | 2018-08-29 | 노파르티스 아게 | Colored contact lens |
US9097840B2 (en) | 2012-12-14 | 2015-08-04 | Novartis Ag | Amphiphilic siloxane-containing (meth)acrylamides and uses thereof |
US9151873B2 (en) | 2012-12-14 | 2015-10-06 | Novartis Ag | Actinically-crosslinkable amphiphilic prepolymers |
EP2931733B1 (en) | 2012-12-14 | 2016-10-05 | Novartis AG | Tris(trimethyl siloxy)silane vinylic monomers and uses thereof |
WO2014093751A2 (en) | 2012-12-14 | 2014-06-19 | Novartis Ag | Amphiphilic siloxane-containing vinylic monomers and uses thereof |
WO2015066255A1 (en) | 2013-10-31 | 2015-05-07 | Novartis Ag | Method for producing ophthalmic lenses |
WO2015089285A1 (en) | 2013-12-13 | 2015-06-18 | Novartis Ag | Method for making contact lenses |
WO2015164630A1 (en) | 2014-04-25 | 2015-10-29 | Novartis Ag | Carbosiloxane vinylic monomers |
EP3134461B1 (en) | 2014-04-25 | 2018-02-14 | Novartis AG | Hydrophilized carbosiloxane vinylic monomers |
WO2016032926A1 (en) | 2014-08-26 | 2016-03-03 | Novartis Ag | Method for applying stable coating on silicone hydrogel contact lenses |
US10160141B2 (en) | 2014-11-25 | 2018-12-25 | Novartis Ag | Molds for making contact lenses |
EP3268804B1 (en) | 2015-03-11 | 2020-11-04 | University of Florida Research Foundation, Inc. | Mesh size control of lubrication in gemini hydrogels |
EP3303415B1 (en) | 2015-06-02 | 2022-12-28 | Alcon Inc. | Visible-light photoinitiators and uses thereof |
CN108290359B (en) | 2015-12-03 | 2020-04-17 | 爱尔康公司 | Contact lens packaging solution |
SG11201803726VA (en) | 2015-12-15 | 2018-06-28 | Novartis Ag | Method for applying stable coating on silicone hydrogel contact lenses |
WO2017103785A1 (en) | 2015-12-15 | 2017-06-22 | Novartis Ag | Method for producing contact lenses with a lubricious surface |
EP3419961B1 (en) | 2016-02-22 | 2020-09-02 | Alcon Inc. | Uv/visible-absorbing vinylic monomers and uses thereof |
US10254567B2 (en) | 2016-02-22 | 2019-04-09 | Novartis Ag | UV-absorbing vinylic monomers and uses thereof |
EP3610321A1 (en) | 2017-04-13 | 2020-02-19 | Novartis AG | Colored contact lenses and method of making the same |
US10156736B2 (en) | 2017-04-13 | 2018-12-18 | Novartis Ag | Colored contact lenses and method of making the same |
US10809181B2 (en) | 2017-08-24 | 2020-10-20 | Alcon Inc. | Method and apparatus for determining a coefficient of friction at a test site on a surface of a contact lens |
EP3676082A1 (en) | 2017-08-29 | 2020-07-08 | Alcon Inc. | Cast-molding process for producing contact lenses |
CA3083649A1 (en) | 2017-12-11 | 2019-06-20 | Innovative Surface Technologies, Inc. | Polyurea copolymer coating compositions and methods |
US11256003B2 (en) | 2017-12-13 | 2022-02-22 | Alcon Inc. | Weekly and monthly disposable water gradient contact lenses |
SG11202004722WA (en) | 2018-01-22 | 2020-08-28 | Alcon Inc | Cast-molding process for producing uv-absorbing contact lenses |
WO2020100090A1 (en) | 2018-11-15 | 2020-05-22 | Alcon Inc. | Contact lens with phosphorylcholine-modified polyvinylalcohols therein |
EP3953744A1 (en) | 2019-04-10 | 2022-02-16 | Alcon Inc. | Method for producing coated contact lenses |
US11602910B2 (en) | 2019-05-28 | 2023-03-14 | Alcon Inc. | Pad transfer printing method for making colored contact lenses |
US20210271109A1 (en) | 2019-12-19 | 2021-09-02 | Alcon Inc. | Cosmetic contact lens for color blindness |
US20240216823A1 (en) | 2020-04-28 | 2024-07-04 | Diamant Toys Ltd | Gaming kits and methods of playing with housings reconfigurable by retrievable unlocking elements |
EP4240578A1 (en) | 2020-11-04 | 2023-09-13 | Alcon Inc. | Method for making photochromic contact lenses |
US11975499B2 (en) | 2020-11-04 | 2024-05-07 | Alcon Inc. | Method for making photochromic contact lenses |
EP4304843A1 (en) | 2021-03-08 | 2024-01-17 | Alcon Inc. | Method for making photochromic contact lenses |
WO2022201072A1 (en) | 2021-03-24 | 2022-09-29 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
KR20230144635A (en) | 2021-04-01 | 2023-10-16 | 알콘 인코포레이티드 | Method for manufacturing embedded hydrogel contact lenses |
WO2022208447A1 (en) | 2021-04-01 | 2022-10-06 | Alcon Inc. | Embedded hydrogel contact lenses |
US20230339149A1 (en) | 2022-04-26 | 2023-10-26 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
WO2023209569A1 (en) | 2022-04-26 | 2023-11-02 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
TW202402514A (en) | 2022-05-09 | 2024-01-16 | 瑞士商愛爾康公司 | Method for making embedded hydrogel contact lenses |
US20230374306A1 (en) | 2022-05-23 | 2023-11-23 | Alcon Inc. | Uv/hevl-filtering contact lenses |
TW202413071A (en) | 2022-05-25 | 2024-04-01 | 瑞士商愛爾康公司 | Method for making embedded hydrogel contact lenses |
US20240316886A1 (en) | 2023-03-22 | 2024-09-26 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3503942A (en) * | 1965-10-23 | 1970-03-31 | Maurice Seiderman | Hydrophilic plastic contact lens |
US4254065A (en) * | 1979-04-04 | 1981-03-03 | Ratkowski Donald J | Injection molding of contact lenses |
US4359558A (en) * | 1980-11-12 | 1982-11-16 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions |
US4454309A (en) * | 1980-11-12 | 1984-06-12 | Tyndale Plains-Hunter, Ltd. | Polyurethane polyene compositions |
US4408023A (en) * | 1980-11-12 | 1983-10-04 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions useful for contact lenses and the like |
US4430458A (en) * | 1981-10-08 | 1984-02-07 | Kelvin Lenses Limited | Hydrogel-forming polymeric materials |
FR2539135B1 (en) * | 1983-01-11 | 1986-02-28 | Essilor Int | POLYURETHANE HYDROGELS AND MANUFACTURING METHOD |
US4536554A (en) * | 1984-02-22 | 1985-08-20 | Barnes-Hind, Inc. | Hydrophilic polymers and contact lenses made therefrom |
CA1279741C (en) | 1984-09-28 | 1991-01-29 | Alton J. Gasper | Grouting composition |
US4780488A (en) * | 1986-08-29 | 1988-10-25 | Ciba-Geigy Corporation | Wettable, flexible, oxygen permeable, substantially non-swellable contact lens containing polyoxyalkylene backbone units, and use thereof |
EP0273710B2 (en) * | 1986-12-26 | 1996-10-16 | Nippon Shokubai Kagaku Kogyo Co., Ltd | Resin having high refractive index, process for producing said resin and optical materials composed of said resin |
JPH0788025B2 (en) * | 1987-04-28 | 1995-09-27 | 三菱瓦斯化学株式会社 | Manufacturing method of synthetic resin molded product having uneven wall reinforcement structure |
US4857606A (en) * | 1987-06-05 | 1989-08-15 | Ciga-Geigy Corporation | Wettable, flexible, oxygen permeable, substantially non-swellable contact lens containing polyoxyalkylene backbone units, and use thereof |
US4786657A (en) * | 1987-07-02 | 1988-11-22 | Minnesota Mining And Manufacturing Company | Polyurethanes and polyurethane/polyureas crosslinked using 2-glyceryl acrylate or 2-glyceryl methacrylate |
US4859780A (en) * | 1988-02-26 | 1989-08-22 | Ciba-Geigy Corporation | Hydrophilic modifier monomers |
US5087392A (en) * | 1988-05-31 | 1992-02-11 | Sola Usa, Inc. | Method of mold contact lenses |
CN1039599A (en) * | 1988-07-15 | 1990-02-14 | 上海科学技术大学 | The synthetic method of polyurethane by radiation curing in the air |
US4983702A (en) * | 1988-09-28 | 1991-01-08 | Ciba-Geigy Corporation | Crosslinked siloxane-urethane polymer contact lens |
US5115056A (en) | 1989-06-20 | 1992-05-19 | Ciba-Geigy Corporation | Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymers and contact lenses thereof |
US5039769A (en) * | 1989-10-11 | 1991-08-13 | Ciba-Geigy Coproation | Wettable, flexible, oxygen permeable, substantially non-swellable contact lens containing polyoxyalkylene backbone units, and use thereof |
DE4025776A1 (en) * | 1990-08-14 | 1992-02-20 | Thera Ges Fuer Patente | New curable prepolymers prepn. - from diol-or di:amino-terminated poly:tetra-hydro-furan with di:isocyanate and hydroxy-or amino-acrylate or with isocyanato-acrylate |
US5170192A (en) * | 1990-11-29 | 1992-12-08 | Pilkington Visioncare, Inc. | Oxygen permeable bifocal contact lenses and their manufacture |
TW328535B (en) * | 1993-07-02 | 1998-03-21 | Novartis Ag | Functional photoinitiators and their manufacture |
US5760100B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
US5656210A (en) * | 1995-03-31 | 1997-08-12 | Johnson & Johnson Vision Products, Inc. | Reaction injection molding as a process to prepare contact lenses |
US5674942A (en) * | 1995-03-31 | 1997-10-07 | Johnson & Johnson Vision Products, Inc. | Interpenetrating polymer networks for contact lens production |
TW393498B (en) * | 1995-04-04 | 2000-06-11 | Novartis Ag | The preparation and use of Polysiloxane-comprising perfluoroalkyl ethers |
-
1998
- 1998-09-14 JP JP2000511800A patent/JP4616473B2/en not_active Expired - Fee Related
- 1998-09-14 DE DE69807509T patent/DE69807509T2/en not_active Expired - Lifetime
- 1998-09-14 US US09/508,785 patent/US6479587B1/en not_active Expired - Lifetime
- 1998-09-14 AR ARP980104570A patent/AR017108A1/en unknown
- 1998-09-14 AU AU97432/98A patent/AU9743298A/en not_active Abandoned
- 1998-09-14 WO PCT/EP1998/005826 patent/WO1999014253A1/en active IP Right Grant
- 1998-09-14 EP EP98951391A patent/EP1017734B1/en not_active Expired - Lifetime
- 1998-09-15 ZA ZA988420A patent/ZA988420B/en unknown
Non-Patent Citations (1)
Title |
---|
See references of WO9914253A1 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004024935A2 (en) | 2002-09-13 | 2004-03-25 | Novartis Ag | Process for analyzing the tear fluid |
WO2004030544A1 (en) | 2002-10-03 | 2004-04-15 | Novartis Ag. | Methods and kits for assays of analytes of interest in tears |
US7977430B2 (en) | 2003-11-25 | 2011-07-12 | Novartis Ag | Crosslinkable polyurea prepolymers |
Also Published As
Publication number | Publication date |
---|---|
US6479587B1 (en) | 2002-11-12 |
JP2001516778A (en) | 2001-10-02 |
DE69807509D1 (en) | 2002-10-02 |
EP1017734B1 (en) | 2002-08-28 |
DE69807509T2 (en) | 2003-04-24 |
JP4616473B2 (en) | 2011-01-19 |
AR017108A1 (en) | 2001-08-22 |
WO1999014253A1 (en) | 1999-03-25 |
ZA988420B (en) | 1999-03-16 |
AU9743298A (en) | 1999-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1017734B1 (en) | Crosslinkable polyurea polymers | |
AU727156B2 (en) | Moulded ophthalmic article | |
US7956135B2 (en) | Organic compounds | |
US6221303B1 (en) | Ophthalmic mouldings | |
EP0958315B1 (en) | Moulded ophthalmic article | |
US6492478B1 (en) | Polymers with crosslinkable pendent groups | |
FI86868B (en) | OMAETTADE POLYSILOXANER, POLYMERISERBARA KOMPOSITIONER OCH AV DESSA FRAMSTAELLDA KONTAKTLINSER. | |
US4929692A (en) | Crosslinked copolymers and ophthalmic devices made from vinylic macromers containing perfluoropolyalkyl ether and polyalkyl ether segments and minor amounts of vinylic comonomers | |
EP1169366B1 (en) | Organic compounds | |
DE69017055T2 (en) | Vinyl macromers containing perfluoropolyalkyl ether and polyalkyl ether segments, polymers made therefrom, interpolymers and ophthalmic devices. | |
US6444776B1 (en) | Organic polymers | |
EP1144484B1 (en) | Amphiphilic block copolymers | |
US6734281B2 (en) | Organic polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000103 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB IT |
|
17Q | First examination report despatched |
Effective date: 20010328 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS AG |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR GB IT |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69807509 Country of ref document: DE Date of ref document: 20021002 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20030530 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20060908 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060930 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20080531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071001 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070914 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20140911 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20140910 Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 69807509 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20150914 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160401 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150914 |